CIC and Parkwalk have returned to back patient-focused genomic analysis developer Congenica, bringing its funding total to $85m.
Congenica, a UK-based patient genomic testing service provider based on research from Wellcome Sanger Institute and the UK’s National Health Service (NHS), closed a £39m ($50m) series C round on Friday featuring Cambridge Innovation Capital (CIC), the VC investor focused on the Cambridge, UK ecosystem.
The round was co-led by internet group Tencent and insurance provider Legal & General with participation by Parkwalk Advisors, part of commercialisation firm IP Group, as well as Xeraya Capital, Puhua Capital, IDO Investments…
